Month: August 2015
Certara CEO Honored in PharmaVOICE 100
Dr. Muniz Named as One of the 100 Most Inspiring Leaders in the Life Science Industry PRINCETON, NJ – Aug. 05, 2015 – Certara®, the global biosimulation technology-enabled drug development company, today announced that its Chief Executive Officer, Edmundo Muniz, M.D., Ph.D., has been named one of the PharmaVOICE 100 “Commanders & Chiefs.” Dr. Muniz … Continued
Derivation for Logarithmic Trapezoidal AUC Calculation
Calculating area under the curve requires the use of two separate equations: one is follows the “linear trapezoidal rule” and the other follows the “logarithmic trapezoidal rule.” These equations are normally presented in textbooks without derivations so all you have to do is insert the concentrations and times and you can calculate the area under … Continued
Dan Littman to Give Keynote at Lasker Workshop for International Research Students
Presenters will share best practices and discuss personal experiences pertaining to getting scientific research published PRINCETON, NJ – Aug. 4, 2015 – WIRB-Copernicus Group (WCG), the world’s largest provider of regulatory and ethical review services and software to support clinical research, and Certara®, the global biosimulation technology-enabled drug development company, today announced that the second … Continued
That’s So Meta: How Model-based Meta-analysis Informs Drug Development
Making the right choices in drug development often means the difference between getting a new medication to patients and it ending up in the scrap heap of failed programs. There is a surfeit of publically available information on approved drugs as well as those currently in development. How can sponsors turn clinical trial data into … Continued